|
Mixed Data for Glaxo & THRX Drug
Zacks.com GlaxoSmithKline (GSK) and Theravance, Inc. (THRX) recently announced top-line data from phase III studies conducted with their pipeline candidate, Relovair, for chronic obstructive pulmonary disease (COPD) and asthma. Relovair is a combination of … Breathe Easy: Program Complete, Data Solid |
View full post on asthma – Google News